Neuren Pharmaceuticals (ASX:NEU) - Insights
ASX:NEU · Data intelligence from 39 published articles
Total Articles
39
all time
Materiality Rate
100%
of announcements
Signal Strength
Strong
avg newsworthiness
Positive Tone
51%
of published articles
Publication Activity
Signal Strength Trend
Tone Split
Announcement Types
Impact Profile
Publication Heatmap Sydney time · day × hour
0h6h12h18h
Sun
Mon
Tue
Wed
Thu
Fri
Sat
Less
More
Announcement Signals
How often each theme appears across all enriched announcements for this company.
Capital Impact
Moderate
33% of announcements reference capital raises, buybacks, or funding changes
Legal & Compliance
High
51% of announcements mention regulatory, legal, or compliance matters
Board Changes
Low
2% of announcements involve executive or board-level appointments
Price Guidance
Moderate
36% of announcements include forward price or earnings guidance
Major Contracts
Moderate
24% of announcements reference significant contract wins or losses
Environmental
Low
2% of announcements reference environmental or sustainability impacts
IP & Patents
Low
13% of announcements mention intellectual property or patent activity
Research & Data
High
80% of announcements contain research results or clinical/trial data